JPH0149299B2 - - Google Patents
Info
- Publication number
- JPH0149299B2 JPH0149299B2 JP58032956A JP3295683A JPH0149299B2 JP H0149299 B2 JPH0149299 B2 JP H0149299B2 JP 58032956 A JP58032956 A JP 58032956A JP 3295683 A JP3295683 A JP 3295683A JP H0149299 B2 JPH0149299 B2 JP H0149299B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- represented
- polymer
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 50
- 229920013730 reactive polymer Polymers 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 19
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 10
- 239000000470 constituent Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 125000006239 protecting group Chemical group 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000004434 sulfur atom Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 description 41
- 229920000642 polymer Polymers 0.000 description 35
- 239000000243 solution Substances 0.000 description 35
- -1 Na + Chemical class 0.000 description 31
- 239000000126 substance Substances 0.000 description 28
- 229920002643 polyglutamic acid Polymers 0.000 description 25
- 238000000034 method Methods 0.000 description 23
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 21
- 108060003951 Immunoglobulin Proteins 0.000 description 20
- 102000018358 immunoglobulin Human genes 0.000 description 20
- 231100000433 cytotoxic Toxicity 0.000 description 18
- 230000001472 cytotoxic effect Effects 0.000 description 18
- 229960002989 glutamic acid Drugs 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 14
- 229960003767 alanine Drugs 0.000 description 13
- 239000002244 precipitate Substances 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 230000000259 anti-tumor effect Effects 0.000 description 10
- 239000002246 antineoplastic agent Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 238000009739 binding Methods 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 7
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical group CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 7
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 7
- 125000002228 disulfide group Chemical group 0.000 description 7
- 235000013922 glutamic acid Nutrition 0.000 description 7
- 239000004220 glutamic acid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 6
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 235000004279 alanine Nutrition 0.000 description 6
- 229940041181 antineoplastic drug Drugs 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 229920000298 Cellophane Polymers 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 125000004035 thiopropyl group Chemical group [H]SC([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NRFJZTXWLKPZAV-UHFFFAOYSA-N N-(2-oxo-3-thiolanyl)acetamide Chemical compound CC(=O)NC1CCSC1=O NRFJZTXWLKPZAV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000008206 alpha-amino acids Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 229960004753 citiolone Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
- FXYPGCIGRDZWNR-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-[[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSCCC(=O)ON1C(=O)CCC1=O FXYPGCIGRDZWNR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansÀure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JJGIDUGGQLLVSW-LBPRGKRZSA-N (2s)-2-[2,2-bis(2-chloroethyl)hydrazinyl]-3-phenylpropanoic acid Chemical compound ClCCN(CCCl)N[C@H](C(=O)O)CC1=CC=CC=C1 JJGIDUGGQLLVSW-LBPRGKRZSA-N 0.000 description 1
- REYLLNRLWCBKCM-YFKPBYRVSA-N (2s)-2-acetamido-4-sulfanylbutanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCS REYLLNRLWCBKCM-YFKPBYRVSA-N 0.000 description 1
- BGGHCRNCRWQABU-JTQLQIEISA-N (2s)-2-amino-5-oxo-5-phenylmethoxypentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(=O)OCC1=CC=CC=C1 BGGHCRNCRWQABU-JTQLQIEISA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- KTWIATYFXLGCQQ-UHFFFAOYSA-N 2-[(4-carboxypyridin-2-yl)disulfanyl]pyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(SSC=2N=CC=C(C=2)C(O)=O)=C1 KTWIATYFXLGCQQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- UHBAPGWWRFVTFS-UHFFFAOYSA-N 4,4'-dipyridyl disulfide Chemical compound C=1C=NC=CC=1SSC1=CC=NC=C1 UHBAPGWWRFVTFS-UHFFFAOYSA-N 0.000 description 1
- NUDZXWNVRWSFQI-UHFFFAOYSA-N 4-nitro-2-[(4-nitropyridin-2-yl)disulfanyl]pyridine Chemical compound [O-][N+](=O)C1=CC=NC(SSC=2N=CC=C(C=2)[N+]([O-])=O)=C1 NUDZXWNVRWSFQI-UHFFFAOYSA-N 0.000 description 1
- LMJXSOYPAOSIPZ-UHFFFAOYSA-N 4-sulfanylbenzoic acid Chemical group OC(=O)C1=CC=C(S)C=C1 LMJXSOYPAOSIPZ-UHFFFAOYSA-N 0.000 description 1
- GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical group C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical group OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical group O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical group O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- ISEQANYLRYIGLF-UHFFFAOYSA-N s-(1h-benzimidazole-2-carbonylsulfanyl) 1h-benzimidazole-2-carbothioate Chemical compound C1=CC=C2NC(C(SSC(=O)C=3NC4=CC=CC=C4N=3)=O)=NC2=C1 ISEQANYLRYIGLF-UHFFFAOYSA-N 0.000 description 1
- AHTFMWCHTGEJHA-UHFFFAOYSA-N s-(2,5-dioxooxolan-3-yl) ethanethioate Chemical compound CC(=O)SC1CC(=O)OC1=O AHTFMWCHTGEJHA-UHFFFAOYSA-N 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000003774 sulfhydryl reagent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Polyamides (AREA)
Description
ïœ ç£æ¥äžã®å©çšåé
æ¬çºæã¯ãåŽéã«å€æ°ã®ã«ã«ããã·ã«åºïŒåã¯
ãã®å¡©ïŒãæãããšå
±ã«ãäž»éã®çæ«ç«¯ã«ããªãŒ
ã«åºãå«ã掻æ§åºãæãããåå¿æ§ã«å¯ãã éå
äœã®è£œé æ³ã«é¢ããããããŠãæ¬çºæã®ç®çãšã
ããšããã¯ãè
«ç现èçã®æšçç©ã«çµåèœãæã
ãæè
«çæäœçãšãå¶ã¬ã³å€çã®çŽ°èæ¯ç©ãçµå
ããŠæšçæååå¶ã¬ã³å€ïŒæè
«çå€ïŒçã補é ã
ãã«éããäž¡è
ãæå¹ãã€å¹çè¯ãçµåãããã
ãã«çšããããšãã§ããéåäœãæäŸããããšã«
ããã
ïœ åŸæ¥æè¡
ããçš®ã®çŽ°èã ããéžæçã«æ®ºãããšãç®çãš
ããŠããã®æšç现èãšç¹ç°çã«çµåãããå
ç«ã°
ãããªã³ãçš®ã
ã®çŽ°èæ¯æ§ç©è³ªãšçµåãããè©Šã¿
ããªãããŠãããäŸãã°ãå
ç«ã°ãããªã³ã«ïœâ
ãã¹ïŒïŒâã¯ãããšãã«ïŒã¢ããââããšãã«
ã¢ã©ãã³çãçµåããè€åäœïŒç¹éæ51â61640
å·ïŒãå
ç«ã°ãããªã³ã«ã¡ããã¬ãã»ãŒãçãçµ
åããè€åäœïŒç¹éæ56â65829å·ïŒãå
ç«ã°ãã
ãªã³ã«ã¯ãã©ã ãã·ã«çãçµåããè€åäœïŒç¹é
æ56â65829å·ïŒãå
ç«ã°ãããªã³ã«ãã€ããã€ã·
ã³âçãçµåããè€åäœïŒç¹éæ55â92325
å·ïŒãå
ç«ã°ãããªã³ã«ããŠããã€ã·ã³ãçµåã
ãè€åäœïŒç¹éæ51â144723å·ïŒçãå
¬ç¥ã§ã
ãã
æŽã«ãç¹éæ51â126281å·ã«ã¯ãæè
«çå
ç«ã°
ãããªã³ãšãïŒåååœãå¶ã¬ã³å€ãïŒã500åå
å
±æçµåããŠããéåäœæ
äœïŒäŸãã°ãããªãã«
ã¿ãã³é
žïŒããã¢ããçµåã«ãã€ãŠçµåãããŠæ
è
«çå€ãåŸãããšãé瀺ãããŠããã
ãããã®æ¹æ³ã§åŸããã现èæ¯æ§è€åäœã¯ãè
«
ç现èãšéžæçã«çµåããè
«ç现èã«æ¯æ§ãçºæ®
ããããšãæåŸ
ããããã®ã§ãããéåžžã«èå³ã®
ããè¬å€ã§ãããããããªãã现èæ¯æ§ç©è³ªãçŽ
æ¥å
ç«ã°ãããªã³ã«çµåããå Žåã¯ãå
ç«ã°ãã
ãªã³ã«å€æ°ã®çŽ°èæ¯æ§ç©è³ªãçµåãããšãå
ç«ã°
ãããªã³ã®æåèªè掻æ§ãäœäžããŠããŸãã®ã§ã
ãããå°é£ãåé¿ããããã«ã¯ãå°æ°ã®çŽ°èæ¯æ§
ç©è³ªãçµåããã«ãšã©ããããããªãã
äžæ¹ãéåäœã现èæ¯æ§ç©è³ªã®æ
äœãšããŠçšã
ãå Žåã¯ãäžèšã®é£ç¹ãæ¹åããããšãã§ãããš
èãããããããããç¹éæ51â126281å·èšèŒã®
æ¹æ³ã¯ãéåäœæ
äœã«å€æ°ã®çŽ°èæ¯æ§ç©è³ªãçµå
ããåå¿ãšãéåäœâå¶ã¬ã³å€çµåäœã«å
ç«ã°ã
ããªã³ãçµåããåå¿ãåäžãªåå¿ã®ãããå€æ°
ã®å
ç«ã°ãããªã³ãéåäœæ
äœã«çµåããŠããŸ
ãããã®ããåŸãããè€åäœãåäžãªãã®ãšãªã
åŸãªãã®ã¿ãªãããæ²»çå€ãšããŠçšããã®ãäžé©
åœãªé«ååéç©è³ªãå«ãããšãã€ãåé¡ãçãã
ã®ã§ããã
ïœ çºæã®ç®ç
æ¬çºæè
çã¯ããããå
è¡æè¡ã®æ¬ ç¹ã解決ã
ã¹ãéæç 究ãè¡ã€ãçµæãå
ç«ã°ãããªã³ãšã®
çµååå¿ã«äŸããåå¿åºãïŒã³ã ãå«æããã
ã€ããããšã¯ç°ãªãã现èæ¯æ§ç©è³ªãçµåããã
ãã®ãåå¿åºãå€æ°å«ãéåäœæ
äœãçšæããå
ãå€æ°ã®åå¿åºã«ãã€ãŠå€æ°ã®çŽ°èæ¯æ§ç©è³ªã該
éåäœæ
äœã«çµåããåŸã«ãå
ç«ã°ãããªã³ãšã®
åå¿åºã«ãã€ãŠå
ç«ã°ãããªã³ãšçµåããããšã
ãæé ãèžãããšã«ããã°ãæ²»çå€ãšããŠçšãã
ã®ãäžé©åœãªé«ååç©è³ªãå«ãŸãããã€ãå€æ°ã®
现èæ¯æ§ç©è³ªãçµåããå
ç«ã°ãããªã³â现èæ¯
æ§ç©è³ªè€åäœã補é ãåŸãããšãèŠãåºãããã
ããŠæ¬çºæã¯ããããæè
«çå€ãããã¯åãã®ä»
ã®æšçæååè¬å€ã補é ããéã«æé©ã«äœ¿çšã§ã
ããåå¿æ§éåäœãæäŸãããã®ã§ããã
ïœ çºæã®æ§æåã³äœçš
æ¬çºæã¯æ§æåäœã®60ã¢ã«ïŒ
以äžãåŒããã§
è¡šããããæ§æåäœãããªãã
ãåŒããã«ãããŠãã¯æ°ŽçŽ åååã¯ïŒäŸ¡ã®
éœã€ãªã³ãè¡šãããïœã¯ïŒâïŒã®æŽæ°ãè¡šãããã
åŒïŒ»ïŒœã®æ§æåäœã100ã¢ã«ïŒ
ã§ãªããšãã
æ®ãã®æ§æåäœã¯åŒïŒ»â²ïŒœ
ãåŒïŒ»â²ïŒœã«ãããŠãã¯âïŒâCH3ïŒ
a Industrial Application Field The present invention is directed to the production of highly reactive polymers that have a large number of carboxyl groups (or salts thereof) in their side chains and an active group containing a thiol group at one end of the main chain. Regarding the law. The purpose of the present invention is to manufacture target-directed anti-cancer drugs (anti-tumor drugs) by combining anti-tumor antibodies, etc. that have the ability to bind to targets such as tumor cells, and cytotoxic substances, such as anti-cancer drugs. The object of the present invention is to provide a polymer that can be used to effectively and efficiently bind the two. b. Prior Art For the purpose of selectively killing only certain types of cells, attempts have been made to combine various cytotoxic substances with immunoglobulins that can specifically bind to the target cells. For example, p-
Complex containing bis(2-chloroethyl)amino-L-phenylalanine, etc. (Japanese Patent Application Laid-open No. 51-61640
), a complex in which immunoglobulin is bound to methotrexate, etc. (JP-A-56-65829), a complex in which immunoglobulin is bound to chlorambucil, etc. (JP-A-56-65829), immunoglobulin and mitomycin-C, etc. A complex combining (JP-A-55-92325
(No. 1987), a complex in which daunomycin is bound to immunoglobulin (Japanese Patent Application Laid-open No. 144723/1983), and the like are known. Furthermore, JP-A-51-126281 discloses a method in which an antitumor immunoglobulin and a polymer carrier (e.g., polydaltamic acid) to which 5 to 500 anticancer drug molecules are covalently bonded per molecule are bonded through an amide bond. It is disclosed that an antitumor agent was obtained by using The cytotoxic complexes obtained by these methods are expected to exert toxicity on tumor cells to which they have selectively bound, and are thus very interesting drugs. However, when a cytotoxic substance is directly bound to an immunoglobulin, the antigen recognition activity of the immunoglobulin decreases when a large number of cytotoxic substances are bound to the immunoglobulin.
In order to avoid such difficulties, it is necessary to bind only a small number of cytotoxic substances. On the other hand, when a polymer is used as a carrier for a cytotoxic substance, it is thought that the above-mentioned difficulties can be improved. However, in the method described in JP-A-51-126281, the reaction of binding a large number of cytotoxic substances to a polymer carrier and the reaction of binding an immunoglobulin to a polymer-anticancer drug conjugate are the same reaction. of the immunoglobulin binds to the polymeric carrier, leading to problems such as the resulting complex not only being non-uniform but also containing high molecular weight substances that are unsuitable for use as a therapeutic agent. It is. c. Purpose of the Invention As a result of intensive research to solve the drawbacks of the prior art, the present inventors have discovered that a cell that contains only one reactive group for binding reaction with immunoglobulin and that is different from that reactive group. A polymer carrier containing a large number of reactive groups for binding a toxic substance is prepared, and after first binding a large number of cytotoxic substances to the polymer carrier through the multiple reactive groups, the reactive group with the immunoglobulin is bonded to the polymer carrier. Therefore, by following the procedure of binding with immunoglobulin, an immunoglobulin-cytotoxic substance complex that does not contain polymeric substances unsuitable for use as a therapeutic agent and binds a large number of cytotoxic substances can be obtained. discovered that it is possible to manufacture the body. The present invention provides a reactive polymer that can be optimally used in the production of such antitumor agents or other target-directed drugs. d Structure and operation of the invention In the present invention, 60 mol% or more of the structural units consist of structural units represented by the formula [], In [Formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer of 1-4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are the formula [â²] [In formula ['], R is -H, -CH 3 ,
ãåŒããŸãã¯âCH2OHã§è¡šããã
ãåºã§ãããã
ã§è¡šããããæ§æåäœãããªãããããŠäž»éã®ã¢
ããæ«ç«¯ã«åŒïŒ»âïœïŒœã§è¡šãããã掻æ§åºãæ
ããŠããã
ãåŒâïœïŒœã«ãããŠãã¯ççŽ æ°ïŒãïŒã®ã¢
ã«ãã¬ã³åºãè¡šããã
éå床ãïŒã3000ã®åå¿æ§éåäœã®è£œé æ³ã§ã
ãã
æ¬çºæã®åå¿éåäœã¯ãåŽéã«ååšããå€æ°ã®
ã«ã«ããã·ã«åºïŒåã¯ãã®å¡©ïŒãå©çšããŠããã
ã«å¶ã¬ã³å€çã®çŽ°èæ¯ç©ãçµåããããšãåºæ¥ã
ãŸãäž»éã®çæ«ç«¯ã«ååšãã掻æ§åºãå©çšããŠã
ããã«æè
«çæäœçã®å
ç«ã°ãããªã³ãçµåãã
ããšãåºæ¥ããã®ã§ããã
åŒããã«ãããŠãã¯æ°ŽçŽ åååã¯ïŒäŸ¡ã®éœ
ã€ãªã³ãäŸãã°Na+ïŒK+ïŒNH4 +ã§ãããïœã¯ïŒ
ãïŒã®æŽæ°ãè¡šãããã奜ãŸããã®ã¯ïœãïŒåã¯
ïŒã®å Žåã§ããããªããæ¬çºæã®åå¿æ§éåäœäž
ã«ã¯ãåŒããã§è¡šããããæ§æåäœã®ãã¡ãäŸ
ãã°ïœïŒïŒã®ãã®ãšïœïŒïŒã®ãã®ãæ··åšããŠããŠ
ãè¯ããããããåèšã§ãå
šæ§æåäœã®ãã¡ã®60
ã¢ã«ïŒ
以äžã奜ãŸããã¯80ã¢ã«ïŒ
以äžããã°ãã
ã®ã§ããã
æ¬çºæã®åå¿æ§éåäœäžã«ã¯ãå
šæ§æåäœã®40
ã¢ã«ïŒ
æªæºã®ç¯å²ã§ãåŒããã§è¡šããããæ§æ
åäœä»¥å€ã®æ§æåäœãå«ãŸããŠããŠãããããã
ãã®äŸãšããŠã¯ãäŸãã°Î±äœåŽéã«ã«ã«ããã·ã«
åºïŒåã¯ãã®å¡©ïŒãæããªãã°ãªã·ã³ãã¢ã©ã
ã³ãããšãã«ã¢ã©ãã³ãã»ãªã³çã®Î±âã¢ããé
ž
ãããã
ãããαâã¢ããé
žãããªãæ§æåäœã¯ã现è
æ¯ç©ãšã®çµåã«ã¯äœãé¢äžããªãããåå¿æ§éå
äœã®æ°Žæº¶æ§ã现èæ¯ç©ãçµåããŠåŸãããéåäœ
ã®è溶æ§ã氎溶æ§ã調ç¯ããã®ã«åœ¹ç«ã€å Žåãã
ããåŸã€ãŠãè溶æ§ã氎溶æ§ã®èª¿ç¯ãæ Œå¥ã«å¿
èŠ
ãªãå Žåã«ã¯ããããαâã¢ããé
žãããªãæ§æ
åäœãå«æããªããã®ã®æ¹ãå®çšçã«æå©ã§ã
ãã
åŒããã«ãããŠãã¯æ°ŽçŽ åååã¯é£ãã®ç¡«
é»ååãšå
±ã«æŽ»æ§ãžã¹ã«ãã€ãçµåã圢æããã
åºãè¡šããããåŸè
ãšããŠã¯ãäŸãã°ïŒâããªãž
ã«ããªåºIt is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-a] at the amino terminal of the main chain, In [Formula-a], W represents an alkylene group having 1 to 4 carbon atoms. This is a method for producing a reactive polymer having a degree of polymerization of 5 to 3,000. The reactive polymer of the present invention can bind cytotoxic substances such as anticancer drugs to it by utilizing a large number of carboxyl groups (or salts thereof) present in the side chains.
In addition, by utilizing the active group present at one end of the main chain,
Immunoglobulins such as anti-tumor antibodies can be bound to this. In formula [], Z is a hydrogen atom or a monovalent cation, such as Na + , K + , NH 4 + . m is 1
It represents an integer of ~4, but m is preferably 1 or 2. In addition, in the reactive polymer of the present invention, among the structural units represented by the formula [], for example, those in which m=1 and those in which m=2 may be mixed. These total 60 of the total constituent units.
It is sufficient if it is at least 80 mol%, preferably at least 80 mol%. In the reactive polymer of the present invention, 40
Constituent units other than those represented by the formula [] may be contained within a range of less than mol%. Examples of these include α-amino acids, such as glycine, alanine, phenylalanine, and serine, which do not have a carboxyl group (or a salt thereof) in the α-position side chain. Such a structural unit consisting of an α-amino acid does not participate in any way in binding with a cytotoxic substance, but it regulates the water solubility of the reactive polymer and the lipid solubility and water solubility of the polymer obtained by binding the cytotoxic substance. It may be helpful. Therefore, if there is no particular need to adjust fat solubility or water solubility, it is practically advantageous to use a product that does not contain such a constituent unit consisting of an α-amino acid. In formula [], X represents a hydrogen atom or a group capable of forming an active disulfide bond with an adjacent sulfur atom, and the latter is, for example, a 2-pyridylthio group.
ãåŒãïŒâããªãžã«ããªåº[Formula] 4-pyridylthio group
ãåŒãïŒâã«ã«ããã·âïŒâããã ããšãã«ããªåº[Formula] 3-carboxy-4-nitro phenylthio group
ãåŒãïŒâã«ã«
ããã·âïŒâããªãžã«ããªåº
[Formula] 4-carboxy-2-pyridylthio group
ãåŒãâãªãã·âïŒâã ãªãžã«ããªåº[Formula] N-oxy-2-pi Lysylthio group
ãåŒãïŒâãããããš ãã«ããªåº[Formula] 2-nitrophe Nylthio group
ãåŒãïŒâãããâïŒâ ããªãžã«ããªåº[Formula] 4-nitro-2- Pyridylthio group
ãåŒãïŒâãã³ ãŸãã¢ãŸã€ã«ããªåº[Formula] 2-ben Zothiazoylthio group
ãåŒãïŒâ
ãã³ãŸã€ãããŸã€ã«ããªåº
[Formula] 2-benzimidazoylthio group
ãåŒãåã³ïŒ®âããšãã«ã¢ãã
âNâ²âããšãã«ã€ããã¡ãã«ããªåº
[Formula] and N-phenylamino-N'-phenyliminomethylthio group
ãåŒããããã
åŒããã«ãããŠïŒ·ã¯ïŒäŸ¡ã®ææ©åºãè¡šããã
æ¬çºæã®åå¿æ§éåäœãåŸãéçšåã³ãã®åŸã®å
å¿éçšã§äœãåå¿ã«é¢äžããªãäžæŽ»æ§ãªåºã§ãã
éãç¹ã«éå®ãããªãããããã®åºãšããŠã¯ãäŸ
ãã°ãïŒâã¢ããããããªã³é
žæ®åºïŒâCH2CH2
âïŒã®åŠãçŽéã®ããããã¯ïŒ®âãã³ãŸã€ã«ã·ã¹
ãã€ã³æ®åºThere is a [formula]. In formula [], W represents a divalent organic group,
It is not particularly limited as long as it is an inert group that does not participate in any reaction during the process of obtaining the reactive polymer of the present invention and the subsequent reaction process. These groups include, for example, 2-aminopropionic acid residue (-CH 2 CH 2
-) or N-penzoylcysteine residues such as
ãåŒããâã¢ãã« ãã¢ã·ã¹ãã€ã³æ®åº[Formula] and N-acyl homocysteine residue
ãåŒããã¡ã« ã«ããã³ãã¯é žæ®åºãFormulaãYamel Captosuccinic acid residue
ãåŒãã®åŠãåŽ
é眮æåºãæããã¢ã«ãã¬ã³åºãïŒâã¡ã«ã«ãã
å®æ¯éŠé
žæ®åºAlkylene group having a side chain substituent as shown in [Formula], 4-mercaptobenzoic acid residue
ãåŒãã®åŠã眮æåºãæ
ããªãããããã¯çœ®æåºãæããããšãã¬ã³åºã
æããããããççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åºãç¹
ã«å¥œãŸããã
æ¬çºæã®åå¿æ§éåäœã®ãã¡ãåŒããã«ãã
ãã¯æ°ŽçŽ ååã§ãããã®ãå³ã¡ãäž»éã®ã¢ãã
æ«ç«¯ã«äžèšåŒãâïœã
ãåŒãâïœãã«ãããŠãã®å®çŸ©ã¯åŒãã
ã®å Žåãšåããã
ã§è¡šãããã掻æ§åºãæããŠããåå¿æ§éåäœã
補é ããæ¹æ³ã«ã€ããŠèª¬æããã
ãã®æ¹æ³ã¯ãæ§æåäœã®60ã¢ã«ïŒ
以äžãåèšåŒ
ããã§è¡šããããæ§æåäœãããªããéå床ã
ïŒã3000ã®èŠªæ°Žæ§éåäœã«ãåŒãã
R1SââCOâR2 âŠãã
ãåŒäžãã®å®çŸ©ã¯åŒããã®å Žåãšåãã§ã
ããR1ã¯ããªãŒã«åºã®ä¿è·åºãè¡šãããR2ã¯é£
æ¥ããã«ã«ããã«åºã掻æ§åãåŸãåºãè¡šãããã
ã§è¡šããããä¿è·ãããããªãŒã«åºãå«æããã¢
ã·ã«åå€ãåå¿ããããéåäœã®ã¢ããæ«ç«¯ãã¢
ã·ã«åãã次ãã§ïŒåã¯åæã«ïŒããªãŒã«åºã®ä¿
è·åºãé€å»ããããšã«ããç®çãšããåå¿æ§éå
äœã補é ããæ¹æ³ã§ããã
æ¬æ¹æ³ã§äœ¿çšãããåæã§ãããæ§æåäœã®60
ã¢ã«ïŒ
以äžãåŒããã§è¡šããããæ§æåäœãã
ã«ããéå床ãïŒã3000ã®èŠªæ°Žæ§éåäœãšã¯ãäŸ
ãã°åŒããã«ãããŠïœïŒïŒã®å Žåã«çžåœããã
ãªã¢ã¹ãã©ã®ã³é
žãïœïŒïŒã®å Žåã«çžåœããããª
ã°ã«ã¿ãã³é
žãããã«ã¢ã¹ãã©ã®ã³é
žãšã°ã«ã¿ã
ã³é
žã®å
±éåç©ããåŒããã§è¡šããããšãã§ã
ãªãåäœæ§é ãæããæåãšããŠãäŸãã°ã¢ã©ã
ã³ã®æ§æåäœã40ã¢ã«ïŒ
以å
ã§å«æããã¢ã¹ãã©
ã®ã³é
žâã¢ã©ãã³å
±éåäœãã°ã«ã¿ãã³é
žâã¢ã©
ãã³å
±éåäœçã®èŠªæ°Žæ§éåäœã§ããããããã®
éåäœã¯éåžžã®æ¹æ³ãäŸãã°ãã¢ããé
žã®ïŒ®âã«
ã«ããã·ç¡æ°Žç©ãéååå¿ã«ä»ãããšã«ããæ¹æ³
ã§äœè£œããããã®ãçšããããšãã§ãããå
·äœäŸ
ãæããã°ãγâãã³ãžã«ââã°ã«ã¿ã¡ãŒãã
âã«ã«ããã·ç¡æ°Žç©ã«å°ããéååå¿ã«ä»ãã
åŸã«ãã³ãžã«åºãè±é¢ããããã°ãããªââã°
ã«ã¿ãã³é
žã容æã«åŸãããšãã§ããã
æ¬æ¹æ³ã§äœ¿çšãããããäžã€ã®åæã§ãããåŒ
ããã§è¡šããããä¿è·ãããããªãŒã«åºãå«æ
ããã¢ã·ã«åå€ã«ãããŠãR1ã¯äŸãã°é£æ¥ãã
ç¡«é»ååãšå
±ã«ãžã¹ã«ãã€ãã圢æããåºã§ãã
åŸããäŸãã°ãã¡ãã«ããªåºïŒCH3SâïŒããã
ã«ããªåºïŒCH3CH2CH2CH2SâïŒçã®ã¢ã«ãã«
ããªåºãγâãµã¯ã·ã³ã€ããžã«ãªãã·ã«ã«ããã«
ããããªãã«ããªåºPhenylene groups having no substituents or having substituents as shown in the formula are exemplified, and alkylene groups having 1 to 4 carbon atoms are particularly preferred. Among the reactive polymers of the present invention, those in which X in the formula [] is a hydrogen atom, that is, those having the following formula [-a] at the amino terminal of the main chain [In formula [-a], the definition of W is formula []
Same as in the case of ] A method for producing a reactive polymer having an active group represented by the following will be explained. In this method, a hydrophilic polymer in which 60 mol % or more of the structural units is composed of the structural units represented by the above formula [] and has a degree of polymerization of 5 to 3000 is added with the formula [] R 1 S-W-CO-R 2 ...[] [In the formula, the definition of W is the same as in the case of the formula []. R 1 represents a protecting group for a thiol group. R 2 represents a group capable of activating an adjacent carbonyl group. ] The desired reactive polymer is produced by reacting with an acylating agent containing a protected thiol group represented by the formula, acylating the amino terminal of the polymer, and then (or simultaneously) removing the protecting group for the thiol group. This is a method of manufacturing. 60 of the constituent units that are the raw materials used in this method
A hydrophilic polymer in which mol% or more is composed of structural units represented by the formula [] and has a degree of polymerization of 5 to 3000 is, for example, polyaspartic acid corresponding to the case where m = 1 in the formula [], m = 2 Polyglutamic acid corresponding to the case of , a copolymer of aspartic acid and glutamic acid, and a component having a unit structure that cannot be expressed by the formula [], such as aspartic acid containing up to 40 mol% of alanine constitutional units. Hydrophilic polymers such as alanine copolymers and glutamic acid-alanine copolymers. These polymers can be prepared by a conventional method, for example, by subjecting N-carboxylic anhydride of an amino acid to a polymerization reaction. To give a specific example, poly-L-glutamic acid can be easily obtained by converting γ-benzyl-L-glutamate into N-carboxyanhydride, subjecting it to a polymerization reaction, and then removing the benzyl group. In the acylating agent containing a protected thiol group represented by the formula [ ], which is another raw material used in the present method, R 1 can be, for example, a group that forms a disulfide with the adjacent sulfur atom. For example, alkylthio groups such as methylthio group (CH 3 S-), butylthio group (CH 3 CH 2 CH 2 CH 2 S-), γ-succinimidyloxycarbonylpropionylthio group
ãåŒã
ã®ããšãã眮æã¢ã«ãã«ããªåºïŒâããªãžã«ããª
åº[Formula] Substituted alkylthio group 2-pyridylthio group
ãåŒãïŒâã«ã«ããã·âïŒâãã ãããšãã«ããªåº[Formula] 3-carboxy-4-nito lophenylthio group
ãåŒãçã®æŽ»
æ§ãžã¹ã«ãã€ãã圢æãåŸãåºçãæããããšã
ã§ãããR1ã¯åã¢ã»ãã«åºExamples include groups capable of forming an active disulfide such as [Formula]. R 1 is also an acetyl group
ãåŒãããã ãªãã«åº[Formula] Propi onyl group
ãåŒãã®ããšãã¢ã·ã«åºãã ãã³ãžã«åºAn acyl group such as [Formula], benzyl group
ãåŒããå«ããåŒ
ããã§è¡šããããã¢ã·ã«åå€ã«ãããŠâR2ã¯é£
æ¥ããã«ã«ããã«åºã掻æ§åãåŸãåºãè¡šããã
äŸãã°ããµã¯ã·ã³ã€ããžã«ãªãã·åº
Also includes [formula]. In the acylating agent represented by the formula [], -R 2 represents a group capable of activating the adjacent carbonyl group,
For example, succinimidyloxy group
ãåŒããã©ãããããšããã·åº[Formula] Paranitrophenoxy group
ãåŒããªã©ã®æŽ»æ§ãšã¹ãã«ã®ã¢
ã«ã³ãŒã«æ®åºãïœâããã«ã«ã«ããã·åº
Alcohol residue of active ester such as [Formula], t-butylcarboxy group
ãåŒãã€ãœããã«ãªãã·ã«ã«ã ãã·åº[Formula] Isobutyloxycarbo xy group
ãåŒãã®ããšãé
žç¡æ°Žç©ã®
ã«ã«ãã³é
žæ®åºãã¢ãžãåºãâN3ãçã奜ãŸã
ãçšããããåºã§ãããåŒããã§è¡šããããã¢
ã·ã«åå€ã«ãããŠïŒ·ã¯åŒããã«ããã説æãšå
ãã§ãããåŒããã§è¡šããããä¿è·ãããããª
ãŒã«åºãå«æããã¢ã·ã«åå€ã®å
·äœäŸãæãã
ã°ããµã¯ã·ã³ã€ããžã«ïŒâïŒïŒâããªãžã«ãžããªïŒ
ããããªããŒã
Preferably used groups include carboxylic acid residues of acid anhydrides such as [Formula], azide group [-N 3 ], and the like. In the acylating agent represented by the formula [], W is the same as described in the formula []. A specific example of an acylating agent containing a protected thiol group represented by the formula [] is succinimidyl 3-(2-pyridyldithio).
Propionate
ãåŒããformulaã
ãåŒãïŒâCH2CH2âïŒ[Formula] W=âCH 2 CH 2 â,
ãåŒãïŒããžããªãã¹ïŒãµã¯ã·ã³ã€
ããžã«ããããªããŒã
[Formula]), dithiobis(succinimidylpropionate)
ãåŒãïŒR1ïŒ[Formula] (R 1 =
ãåŒãïŒâCH2CH2âïŒ[Formula] W=âCH 2 CH 2 â,
ãåŒãïŒïŒ®âãã³ãŸã€ã«ã·ã¹ãã³ã
ã©ãããããšãã«ãšã¹ãã«
[Formula], N-benzoylcystine paranitrophenyl ester
ãåŒããformulaã
ãåŒããformulaã
ãåŒããformulaã
ãåŒãçãæããããšãã§
ããããã«äŸãã°ãâã¢ã»ãã«ãã¢ã·ã¹ãã€ã³
ããªã©ã¯ãã³For example, N-acetylhomocysteine thiolactone
ãåŒãã®ããšããããª
ãŒã«åºã®ä¿è·åºãè¡šããR1ãã«ã«ããã«åºã®æŽ»
æ§ååºã§ããR2ãååå
ã«çµã¿èŸŒãŸããŠããå
åç©ãæ¬æ¹æ³ã«äœ¿çšã§ããã
æ¬æ¹æ³ã®åå¿ã«çšãããã芪氎æ§éåäœã«å¯Ÿã
ãŠçšããä¿è·ãããããªãŒã«åºãå«æããã¢ã·ã«
åå€ã¯ïŒåã100ååœéãããã«å¥œãŸããã¯ïŒå
ã100ååœéãçšãããçšãã溶åªã¯ç·©è¡¡æ¶²ïŒPH
ïŒãïŒïŒãDMFçãåäžæº¶æ¶²ã圢æãã溶åªã奜
ãŸãããããªãšãã«ã¢ãã³ãçé
žãœãŒãçã®å¡©åº
ã®ååšäžã§åå¿ãããæå©ã«é²ããããšãã§ã
ããåå¿æž©åºŠã¯ïŒâã50âã奜ãŸããã¯ïŒâã30
âã§ãããåå¿æéã¯ïŒæéãïŒæ¥ã§ããã
åå¿çµäºåŸãåå¿æ¶²ã緩衡液ã®å Žåã¯ãå¡©é
žã
ç¡«é
žçã®é
žãå ããåå¿æ¶²PHïŒä»¥äžãšããçæã
ããä¿è·ãããããªãŒã«åºãæããã¢ã·ã«åºãã¢
ããæ«ç«¯ã«çµåãã芪氎æ§éåäœã®æ²æŸ±ãçãã
ããããããåããæ¹æ³ã«ãããçæç©ã粟補
ãããåå¿æ¶²ã氎以å€ã®æº¶åªã䜿çšããŠããå Žå
ã¯ã緩衡液ãå ããŠãããåæ§ã®æ¹æ³ã«ãã粟補
ã§ãããä»ã«ãéæãã²ã«éã«ãã粟補ããã
ãšãã§ããã
ããããŠåŸããããä¿è·ãããããªãŒã«åºãæ
ããã¢ã·ã«åºãã¢ããæ«ç«¯ã«çµåãã芪氎æ§éå
äœã®ãããªãŒã«åºã®ä¿è·åºãè±é¢ãããã€ãŠç®ç
ç©ã§ãããäž»éã®ã¢ããæ«ç«¯ã«åŒãâïœãã§è¡š
ãããã掻æ§åºãæããŠããåå¿æ§éåäœãåŸã
æ¹æ³ã«ã€ããŠè¿°ã¹ããä¿è·åºãè±é¢ããæ¹æ³ã¯ã
ä¿è·åºã®çš®é¡ã«ãã€ãŠç°ãªããäŸãã°ãåŒãã
ã«ãããŠR1ãé£æ¥ããç¡«é»ååãšå
±ã«ãžã¹ã«ã
ã€ãã圢æããŠããå Žåã¯ããžã¹ã«ãã€ãåºãé
å
çã«åæããæ¹æ³ã奜ãŸããçšãããããäŸã
ã°ïŒâã¡ã«ã«ãããšã¿ããŒã«ããžããªã¹ã¬ã€ããŒ
ã«ãæ°ŽçŽ åããŠçŽ ãããªãŠã çã®éå
å€ã氎溶液
äžã該芪氎æ§éåäœã«äœçšããããšã«ãã€ãŠãã
ããããªãŒã«å«æåºãã¢ããæ«ç«¯ã«æããåå¿æ§
éåäœã«å°ãããšãã§ãããçšããéå
å€ã®éã¯
ïŒã100åœéã奜ãŸãããåå¿æž©åºŠã¯ïŒâã50âã
åå¿æéã¯ïŒåãïŒæéã奜ãŸãããåŒããã«
ãããŠãR1ãã¢ã·ã«åºã®å Žåã¯ãå æ°Žå解ã«ã
ããããè±é¢ãããåå¿ã¯æ°Žæº¶æ¶²äžã觊åªãšããŠ
ããããã·ã«ã¢ãã³ãçé
žãããªãŠã ãæ°Žé
žåã
ããªãŠã çã®ã¢ã«ã«ãªãïŒã100åœéçšããŠãã
ãªããåå¿æž©åºŠã¯ïŒã50âãåå¿æéã¯10åã10
æéã奜ãŸãããåŒããã«ãããŠR1ããã³ãž
ã«åºã®å Žåã¯ãéå°ã®ããªãã«ãªãé
¢é
žãã¡ã¿ã³
ã¹ã«ãã³é
žåã¯ãããã®æ··å液ã§è©²èŠªæ°Žæ§éåäœ
ãåŠçãããåå¿æž©åºŠã¯ïŒâã30âãåå¿æéã¯
30åã10æéã§ããããªããåŒããã§è¡šããã
ãä¿è·ãããããªãŒã«åºãå«æããã¢ã·ã«åå€ãš
ããŠäŸãã°ïŒ®âã¢ã»ãã«ãã¢ã·ã¹ãã€ã³ããªã©ã¯
ãã³ãçšããå Žåã¯ã¢ã·ã«ååå¿ãšåæã«è±ä¿è·
åºåå¿ãé²ããããéããŠè±ä¿è·åºåå¿ãè¡ãªã
å¿
èŠã¯ç¡ãã
ããããŠåŸããããäž»éã®ã¢ããæ«ç«¯ã«åŒã
âïœãã§è¡šãããã掻æ§åºãæããŠããåå¿æ§é
åäœã¯ãäžçŽç©ãšããŠäœååç©è³ªã¯å«æããŠããª
ãããããããåæãšããŠçšãã芪氎æ§éåäœã®
äžéšãæ«åå¿ã®ãŸãŸå«æããŠããå¯èœæ§ãããã
次ã«ããã®æªåå¿ã®é«ååç©è³ªã®é€å»ããããš
ãšã«ãããçæç©ãããã«ç²Ÿè£œããæ¹æ³ã«ã€ããŠ
è¿°ã¹ãããã®ç²Ÿè£œã¯ãäŸãã°ããªãããã«ã»ãã¢
ããŒã¹6B
ïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒã§äŸç€ºããã
æ§ãªãããªãŒã«åºãå«æããååç©ãçµåããæš¹
èãçšããŠç·©è¡¡æ¶²äžã¯ãããã°ã©ãã€ãŒãæœè¡ã
ãããšã«ããæããããå³ã¡ãæªç²Ÿè£œã®åå¿æ§é
åäœã該ã«ã©ã ã«éããšãã¢ããæ«ç«¯ã«ããªãŒã«
å«æåºãå«ãåå¿æ§éåäœã¯ã«ã©ã ã«çµåããäž
çŽç©ã§ãããããªãŒã«å«æåºãå«ãŸãªãéåäœã¯
溶åºãããã次ãã§ã«ã©ã ã«ïŒâã¡ã«ã«ãããšã¿
ããŒã«ããžããªã¹ã¬ã€ããŒã«çã®ç·©è¡¡æº¶æ¶²ãéã
ãšã粟補ããããããªãŒã«å«æåºãå«ãåå¿æ§é
åäœã溶åºããã溶åºæ¶²ã¯ãé
žæ§ãšããŠéåäœã
æ²æŸ±ãšããããåã¯éæããŠäœååç©è³ªãé€ãã
åçµä¹Ÿç¥ãæœããŠãç®çç©ãåŸãããšãã§ããã
次ã«ãæ¬çºæã®åå¿æ§éåäœã®ãã¡ãåŒãã
ã«ããããé£ãã®ç¡«é»ååãšå
±ã«æŽ»æ§ãžã¹ã«ã
ã€ãçµåã圢æãããåºãè¡šããå Žåãå³ã¡ãäž»
éã®ã¢ããæ«ç«¯ã«äžèšåŒãâïœã
ãåŒãâïœãã«ãããŠãã®å®çŸ©ã¯åèšåŒ
ããã®å ŽåãšåããX1ã¯é£ãã®ç¡«é»ååãšå
±ã«
掻æ§ãžã¹ã«ãã€ãçµåã圢æãããåºãè¡šãããã
ã§è¡šãããã掻æ§åºãæããŠããåå¿æ§éåäœã
補é ããæ¹æ³ã«ã€ããŠèª¬æããã
ãã®æ¹æ³ã¯ãã¢ããæ«ç«¯ã«åèšåŒãâïœãã§
è¡šãããã掻æ§åºãå«æããéåäœãå³ã¡ãããª
ãŒã«åºãå«æããéåäœãšã掻æ§ãžã¹ã«ãã€ãå
åç©ãåå¿ãããæ¹æ³ã§ããã掻æ§ãžã¹ã«ãã€ã
ååç©ãšããŠã¯ãäŸãã°ãïŒâããªãžã«ãžã¹ã«ã
ã€ãCompounds such as [Formula] in which R 1 representing a protecting group for a thiol group and R 2 representing an activating group for a carbonyl group are incorporated into the molecule can also be used in this method. The acylating agent containing a protected thiol group used for the hydrophilic polymer used in the reaction of this method is used in an amount of 1 to 100 times equivalent, more preferably 5 times to 100 times equivalent. The solvent used is a buffer solution (PH
5 to 8), solvents that form a homogeneous solution, such as DMF, are preferred. The reaction can also proceed more advantageously in the presence of a base such as triethylamine or sodium carbonate. The reaction temperature is 0°C to 50°C, preferably 4°C to 30°C.
It is â. Reaction time is 1 hour to 3 days. After the reaction is complete, if the reaction solution is a buffer solution, add hydrochloric acid,
The product is obtained by adding an acid such as sulfuric acid to lower the pH of the reaction solution to 4 or below, causing a precipitate of a hydrophilic polymer in which an acyl group having a protected thiol group is bonded to the amino terminal, and removing the precipitate. refine. If the reaction solution uses a solvent other than water, it can be purified in the same manner after adding a buffer solution. Alternatively, it can be purified by dialysis or gel filtration. The protecting group of the thiol group of the thus obtained hydrophilic polymer in which an acyl group having a protected thiol group is bonded to the amino terminal is removed, and the desired product, the amino terminal of the main chain, is bonded with the formula A method for obtaining a reactive polymer having an active group represented by [-a] will be described. The method for removing the protecting group is
Depends on the type of protecting group. For example, the expression []
When R 1 forms a disulfide together with the adjacent sulfur atom, a method of reductively cleaving the disulfide group is preferably used. For example, by acting on the hydrophilic polymer in an aqueous solution with a reducing agent such as 2-mercaptoethanol, dithiothreitol, or sodium borohydride, it is converted into a reactive polymer having a thiol-containing group at the amino terminal. can lead. The amount of reducing agent used is preferably 1 to 100 equivalents. Reaction temperature is 0â~50â,
The reaction time is preferably 1 minute to 3 hours. In formula [], when R 1 is an acyl group, it is eliminated by hydrolysis. The reaction is carried out in an aqueous solution using 1 to 100 equivalents of an alkali such as hydroxylamine, sodium carbonate, or sodium hydroxide as a catalyst. Reaction temperature is 0 to 50â, reaction time is 10 minutes to 10 minutes.
time is preferable. When R 1 is a benzyl group in formula [], the hydrophilic polymer is treated with excess trifluoroacetic acid, methanesulfonic acid, or a mixture thereof. Reaction temperature is 0â~30â, reaction time is
30 minutes to 10 hours. In addition, when N-acetylhomocysteine thiolactone is used as an acylating agent containing a protected thiol group represented by formula [], the deprotecting group reaction proceeds simultaneously with the acylation reaction, so the deprotecting group is overlapped. There is no need to perform a reaction. At the amino terminal of the main chain thus obtained, the formula [
The reactive polymer having an active group represented by -a] does not contain any low-molecular substances as impurities, but it does contain a part of the hydrophilic polymer used as a raw material in an unreacted form. There is a possibility that it is. Next, a method for further purifying the product by removing this unreacted polymeric substance will be described. Its purification is accomplished by performing chromatography in a buffer using a resin that binds a compound containing a thiol group, such as thiopropyl sepharose 6B (manufactured by Pharmacia). . That is, when an unpurified reactive polymer is passed through the column, the reactive polymer containing a thiol-containing group at the amino end binds to the column, and the impurity, a polymer that does not contain a thiol-containing group, is eluted. . A buffered solution such as 2-mercaptoethanol or dithiothreitol is then passed through the column to elute the purified reactive polymer containing thiol-containing groups. The eluate is acidified to precipitate the polymer or dialyzed to remove low-molecular substances.
The desired product can also be obtained by freeze-drying. Next, among the reactive polymers of the present invention, formula []
When X in represents a group capable of forming an active disulfide bond with the adjacent sulfur atom, that is, the following formula [-a] is present at the amino terminal of the main chain: [In formula [-b], the definition of W is the same as in the above formula []. X 1 represents a group capable of forming an active disulfide bond with the adjacent sulfur atom. ] A method for producing a reactive polymer having an active group represented by the following will be explained. The method is to react a polymer containing an active group represented by the above formula [-a] at the amino terminal, that is, a polymer containing a thiol group, with an active disulfide compound. As the active disulfide compound, for example, 2-pyridyl disulfide
ãåŒãïŒâããªãžã« ãžã¹ã«ãã€ã[Formula] 4-pyridyl disulfide
ãåŒãïŒïŒ
5â²âãžããªãã¹ïŒïŒâãããå®æ¯éŠé
žïŒ
[Formula] 5, 5'-dithiobis(2-nitrobenzoic acid)
ãåŒãïŒâã«
ã«ããã·âïŒâããªãžã«ãžã¹ã«ãã€ã
âãªãã·âïŒâããªãžã«ãžã¹ã«ãã€ã
[Formula] 4-carboxy-2-pyridyl disulfide N-oxy-2-pyridyl disulfide
ãåŒãïŒâãããããšã ã«ãžã¹ã«ãã€ã[Formula] 2-nitropheni Ludisulfide
ãåŒãïŒ
âãããâïŒâããªãžã«ãžã¹ã«ãã€ã
[Formula] 4-nitro-2-pyridyl disulfide
ãåŒãïŒâã
ã³ãŸãã¢ãŸã€ã«ãžã¹ã«ãã€ã
[Formula] 2-benzothiazoyl disulfide
ãåŒãïŒâã
ã³ãŸã€ãããŸã€ã«ãžã¹ã«ãã€ã
[Formula] 2-benzimidazoyl disulfide
ãåŒãâã
ãšãã«ã¢ããâNâ²âããšãã«ã€ããã¡ãã«ãžã¹
ã«ãã€ã
ãæããããšãã§ããã
äž¡è
ã®åå¿ã¯ãéåžžãæ°Žåã¯ãžã¡ãã«ãã«ã ã¢
ããããžã¡ãã«ã¹ã«ããã·ãçã®ææ©æº¶å€ãåå¿
溶åªãšããåäžåå¿ç³»ã§è¡ãªãããããããã¯ãŸ
ããéåäœã®æ°Žæº¶æ¶²ã«æŽ»æ§ãžã¹ã«ãã€ãååç©å
ã¯ãã®ã¢ã»ãã³æº¶æ¶²åã¯ãžãªããµã³æº¶æ¶²çãæ·»å
æ··åããåå¿ç³»ã§è¡ãªãããšãã§ãããåå¿æž©åºŠ
ã¯âïŒâã70âãåå¿æéã¯ïŒåã24æéãé©åœ
ã§ããã
åå¿åŸã®ç²Ÿè£œã¯ãåå¿æ¶²ã«ç·©è¡¡æ¶²ãå ããåŸã
é
žæ§ã«ããéåäœãæ²æŸ±ããããåããæ¹æ³ã
åå¿æ¶²ãéæããã®ã¡ãåçµä¹Ÿç¥ãæœè¡ããæ¹æ³
çã«ããã容æã«æœè¡ããããšãã§ããã
次ã«ãããããŠåŸãããäž»éã®ã¢ããæ«ç«¯ã«åŒ
ãâïœãã§è¡šãããã掻æ§åºãæããŠããåå¿
æ§éåäœããäž»éã®ã¢ããæ«ç«¯ã«åŒãâïœãã§
è¡šãããã掻æ§åºãæããŠããåå¿æ§éåäœã«å€
æããæ¹æ³ã«ã€ããŠè¿°ã¹ãããã®æ¹æ³ã¯ããžã¹ã«
ãã€ãåºãéå
çã«åæããæ¹æ³ã奜ãŸãããçš
ããããéå
å€ã¯ãäŸãã°ïŒâã¡ã«ã«ãããšã¿ã
ãŒã«ããžããªã¹ã¬ã€ããŒã«çã®ããªãŒã«é¡ãæ°ŽçŽ
åããŠçŽ ãããªãŠã ãæ°ŽçŽ åããŠçŽ ã«ã«ã·ãŠã ç
ã®æ°ŽçŽ åããŠçŽ ååç©çã䜿çšããããåå¿æº¶åª
ã¯ãæ°Žãåã¯ãžã¡ãã«ãã«ã ã¢ããã奜ãŸããã
çšããéå
å€ã®éã¯ïŒã100åœéã奜ãŸãããå
å¿æž©åºŠã¯ïŒã50âãåå¿æéã¯ïŒåãïŒæéã奜
ãŸããã粟補ã¯ãéåžžã®é
žã«ããæ²æŸ±æ³ãã²ã«
éæ³ãéææ³çã«ãããããªãã
æ¬çºæã®åå¿æ§éåäœã¯ãåŽéã«åå¿æ§ã«å¯ã
ã å€æ°ã®ã«ã«ããã·ã«åºïŒåã¯ãã®å¡©ïŒãæãã
ååæ«ç«¯ã«åå¿æ§ã«å¯ãã ããªãŒã«åºåã¯æŽ»æ§ãž
ã¹ã«ãã€ãçµåãæããŠããã®ã§ããããã®åºã®
åå¿æ§ãå©çšããŠãäŸãã°ä»¥äžã«è¿°ã¹ãåŠãæ¹æ³
ã§å
ç«ã°ãããªã³ãšçŽ°èæ¯ç©ãæå¹ãã€å¹çè¯ã
çµåãããããšãã§ããåŸãããçµåç©ã¯ãæšç
æååã®è¬å€ãšããŠçšããããšãã§ããã
åŽéã«å°å
¥ããã现èæ¯ç©ãšããŠã¯ãäŸãã°å
åäžã«ã¢ããåºåã¯ã€ããåºãå«ãå¶ã¬ã³å€çã
çšããããããããŠæ¬çºæã®åå¿æ§éåäœãšçŽ°è
æ¯ç©ãšã®åå¿ã¯ãéåžžãæ°Žåã¯ãžã¡ãã«ãã«ã ã¢
ããããžã¡ãã«ã¹ã«ããã·ãçã®ææ©æº¶å€ãåå¿
溶åªãšããåäžåå¿ç³»ã§è¡ãªããããåå¿ã«éã
ãŠã¯ãäŸãã°ïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢
ãããããã«ïŒã«ã«ããžã€ããå¡©é
žå¡©ããžã·ã¯ã
ããã·ã«ã«ã«ããžã€ããã§éåäœäžã®ã«ã«ããã·
ã«åºã掻æ§åããŠãããããããã¯ã«ã«ããã·ã«
åºãæ··åé
žç¡æ°Žç©ã®åœ¢ã«æŽ»æ§åããŠãããŠãã
ããåå¿æž©åºŠã¯â40âã100âãåå¿æéã¯10å
ã10æ¥éãé©åœã§ããã
ïœ
çºæã®å¹æ
ããããŠåŸããã现èæ¯ç©ãåŽéã«çµåããå
å¿æ§éåäœã¯ãååæ«ç«¯ã«ãªãåå¿æ§ã«å¯ãã ã
ãªãŒã«åºåã¯æŽ»æ§ãžã¹ã«ãã€ãçµåãæããŠãã
ã®ã§ããããåºåã¯çµåã®åå¿æ§ãšãæè
«çå
ç«
ã°ãããªã³åã¯ãã®ãã©ã°ã¡ã³ãã«çºçåã¯å°å
¥
ããããªãŒã«åºã掻æ§ãžã¹ã«ãã€ãåºããã¬ã€ã
ãåºçã®åå¿æ§ãå©çšããŠäž¡è
ãçµåããã现è
æ¯ç©ã®çµåããæ¬çºæã®åå¿æ§éåäœãæ¯æ§éšãš
ããæè
«æ§ãæããè€åäœã補é ããããšãã§ã
ããå
·äœçã«è£œé æ³ãšããŠã¯ãäŸãã°ä»¥äžã®åŠã
æ¹æ³ãããã
æè
«çå
ç«ã°ãããªã³ãããã·ã³åŠçãã
Fabâ²ã®ïŒéäœãåŸããã®ãã³ãžéšåã®ãžã¹ã«
ãã€ãçµåããäŸãã°ããªãŒã«è©Šè¬ã«ããéå
çã«åæããŠååäžã«ããªãŒã«åºãæãã
Fabâ²ãåŸãããããŠããªãŒã«åºãæãã
Fabâ²ãšã掻æ§ãžã¹ã«ãã€ãçµåãæããæ¬çº
æã®åå¿æ§éåäœã«ããã«çŽ°èæ¯æ§ç©è³ªãçµå
ããéåäœãåå¿ãããç®çãšããæè
«çæ§è€
åäœãåŸãã
æè
«çæ§å
ç«ã°ãããªã³ã«ãäŸãã°ãµã¯ã·ã³
ã€ããžã«ïœâãã¬ã€ãããã³ãŸãšãŒããäœçšã
ãããšã«ãããã¬ã€ããåºãå°å
¥ããå
ç«ã°ã
ããªã³ã«ãããªãŒã«åºãæããæ¬çºæã®åå¿æ§
éåäœã«ããã«çŽ°èæ¯æ§ç©è³ªãçµåããéåäœ
ãåå¿ãããç®çãšããæè
«çæ§è€åäœãåŸ
ãã
ããããŠåŸãããæè
«çå€ã¯ãè
«ç现èãšéžæ
çã«çµåããè
«ç现èã«æ¯æ§ãçºæ®ããããšãæ
åŸ
ããããã®ã§ããã
以äžãå®æœäŸã«ããæ¬çºæã詳述ããã
å®æœäŸ ïŒ
ïŒâïŒ ã¢ããæ«ç«¯ïŒä»¥äžïŒ®âæ«ç«¯ãšçç¥ïŒã«ä¿
è·ãããããªãŒã«åºãå«ãã¢ã·ã«åºãå°å
¥ãã
ãããªââã°ã«ã¿ãã³é
žã®è£œé ã
ããªââã°ã«ã¿ãã³é
žã®ãããªãŠã å¡©ïŒå¹³å
ååé21000ïŒ226.5mgã®0.1Mãªã³é
žãããªãŠã
緩衡液ïŒPH7.5ïŒïŒ15mlïŒäžæº¶æ¶²ã«ãâãµã¯ã·ã€
ããžã«ïŒâïŒïŒâããªãžã«ãžããªïŒããããªããŒ
ãïŒä»¥äžSPDPãšçç¥ããïŒ68.8mgã®ãšã¿ããŒã«
ïŒïŒmlïŒæº¶æ¶²ãæ¹æäžãïŒåºŠã«åããŠå ãã1.5æ
é宀枩äžã«åå¿ããããåå¿æ¶²ãã»ããã¢ã³éæ
ããŠãŒãã«å
¥ãã0.01Mãªã³é
žç·©è¡¡æ¶²ïŒPH7.5ïŒ
ã«å¯ŸããŠïŒâã§ïŒæ¥ééæããŠäœååç©è³ªãé€å»
ãããšãããªââã°ã«ã¿ãã³é
žååã®ã¢ããæ«
端ã«ïŒâïŒïŒâããªãžã«ãžããªïŒããããªãã«åº
ãã¢ããçµåã«ããå°å
¥ãããŠçæãããžã¹ã«ã
ã€ãçµåãæããããªââã°ã«ã¿ãã³é
žãå«æ
ãã溶液50mlãåŸãããã
ïŒâïŒ ïŒ®âæ«ç«¯ã«ããªãŒã«åºãæããããªâ
âã°ã«ã¿ãã³é
žã®è£œé ã
ïŒâïŒïŒã«ãã€ãŠåŸããããã¢ããæ«ç«¯ã«ïŒâ
ïŒïŒâããªãžã«ãžããªïŒããããªãã«åºãå°å
¥ã
ãããžã¹ã«ãã€ãçµåãæããããªââã°ã«ã¿
ãã³é
žãå«æãã溶液50mlã«ããžããªã¹ã¬ã€ããŒ
ã«17mgã®0.1Mãªã³é
žãããªãŠã ïŒPH6.0ïŒç·©è¡¡æ¶²
2.0mläžæº¶æ¶²ãå ãã宀枩äžã«80åéåå¿ãããã
次ãã§å¡©é
žé
žæ§ãšããçããæ²æŸ±ãé å¿åé¢ã
ããåŸãããããªââã°ã«ã¿ãã³é
žã®ãæ²æŸ±ç©
ïŒæ«ç«¯ã«ããªãŒã«åºãæããããªââã°ã«ã¿ã
ã³é
žãšæããªãããªââã°ã«ã¿ãã³é
žãå«ããïŒ
ã¯ã0.01NHClã§æŽæµããã
äžæ¹ãããªãããã«ã»ãã¢ããŒã¹6Bã²ã«
ïŒThiopropyl Sepharse
6Bããã¢ã«ãã·ã¢ç€Ÿ
補ïŒ15mlã0.1Mãªã³é
žãããªãŠã ïŒPH6.0ïŒâ
1mMãšãã¬ã³ãžã¢ãã³ããã©é
¢é
žïŒä»¥åŸEDTA
ãšçç¥ããïŒïŒPH6.0ïŒç·©è¡æ¶²40mlã«åæ£ããåŸã
ããåæ£æº¶æ¶²ã«ãåèšã§åŸãããããªââã°ã«
ã¿ãã³é
žãåäžç·©è¡¡æ¶²10mlã«æº¶è§£ããŠåŸããã溶
液ãå ãã宀枩äžãçªçŽ é°å²æ°äžã§ããããã«ïŒ
å€æ¹æãããããã§æ«ç«¯ã«ããªãŒã«åºãæããã
ãªââã°ã«ã¿ãã³é
žãæš¹èã«çµåããã次ãã§
æš¹èããå¥ãã0.01Mãªã³é
žç·©è¡¡æ¶²PH7.5ã§å
å
æŽæµããã
ããããŠåŸãããæš¹èã0.1Mããªã¹âå¡©é
žâ
1m MEDEAïŒPH8.5ïŒç·©è¡¡æ¶²50mlã«åæ£ãïŒâã¡
ã«ã«ãããšã¿ããŒã«1.17ïœãå ãã宀枩äžçªçŽ é°
å²æ°äžã§10æéããããã«æ¹æãããããã§æ«ç«¯
ãããªãŒã«åºã®ããªââã°ã«ã¿ãã³é
žãæš¹èã
ãéé¢ããã
æš¹èãæ¿Ÿå¥ãã0.01Mããªã¹âå¡©é
žâ0.1m
MEDTAïŒPH8.5ïŒç·©è¡¡æ¶²ã§ããæŽæµãã次ãã§ã
濟液ãšæŽæ¶²ãæ°·å·äžå¡©é
žã§PH1.8ãšããçããæ«
端ã«ããªãŒã«åºãæããããªââã°ã«ã¿ãã³é
ž
ã®æ²æŸ±ãé å¿åé¢ããã
ïŒâïŒ ïŒ®âæ«ç«¯ã«æŽ»æ§ãžã¹ã«ãã€ãåºãæãã
ããªââã°ã«ã¿ãã³é
žã®è£œé ã
ïŒâïŒïŒã§åŸãããæ«ç«¯ã«ããªãŒã«åºãæãã
ããªââã°ã«ã¿ãã³é
žã®æ²æŸ±ããåã³0.4Mãª
ã³é
žãããªãŠã â1mMEDTAïŒPH7.5ïŒç·©è¡¡æ¶²ïŒ
mlã«æº¶è§£ããåŸããã溶液ãïŒâããªãžã«ãžã¹ã«
ãã€ãïŒä»¥äžïŒâPDSãšçç¥ããïŒ23mgã®ãšã¿
ããŒã«ïŒïŒmlïŒæº¶æ¶²ã0.1Mãªã³é
žãããªãŠã â
1m MEDTAïŒPH6.0ïŒ10mlã«å ããŠåŸããã溶液
ã«å ãã宀枩äžã§30åéåå¿ãããåŸãïŒããªâ
âã°ã«ã¿ãã³é
žã®æ«ç«¯ã掻æ§ãžã¹ã«ãã€ãåºãš
ãªãïŒåå¿æ¶²ãã»ããã¢ã³ããŠãŒãã«å
¥ãã
0.01Mãªã³é
žãããªãŠã ïŒPH7.5ïŒç·©è¡¡æ¶²ã«å¯Ÿã
ãŠïŒæéãçŽãã«å¯ŸããŠãïŒæ¥éæãããåå液
ãæžå§ã§30mlã«æžå°ããåçµä¹Ÿç¥ãããšãæ«ç«¯ã«
ïŒâããªãžã«ãžããªåºãå°å
¥ãããããªââã°
ã«ã¿ãã³é
žïŒãããªãŠã å¡©ïŒã®ç¶¿ç¶åºäœ35.4mgã
åŸãããïŒééåç15.6ïŒ
ïŒãå®æœäŸïŒâïŒïŒã®
çµæãããåŸãããéåäœã¯æ«ç«¯ã«ïŒâããªãžã«
ãžããªåºãå«æããŠããååéã¯17800ã§ããã
ïŒâïŒ ïŒ®âæ«ç«¯ã«ããªãŒã«åºãæããããªâ
âã°ã«ã¿ãã³é
žã®è£œæ³ã
äžå®éã®ãµã³ãã«ã粟秀ãïŒ1.895mgïŒã3.00ml
ã®0.1Mãªã³é
žãããªãŠã 緩衡液ïŒPH7.2ïŒã«æº¶è§£
ãããžããªã¹ã¬ã€ããŒã«ã®å°çãå ããéé¢ãã
ïŒâã¡ã«ã«ããããªãžã³ã«ç±æ¥ããåžå
ïŒ343nmãåååžå
ä¿æ°ÎµïŒ8080ïŒã枬å®ãã
ïŒïŒ¡ïŒ0.286ïŒã粟秀ããããµã³ãã«äžã®æ«ç«¯åºé
ã¯0.1062ÎŒmoleãåŸã€ãŠãåãµã³ãã«äžã®æ«ç«¯æŽ»
æ§ãžã¹ã«ãã€ãå«æããªââã°ã«ã¿ãã³é
žåå
ã®ååéã¯17800ãåãåååäžã®ã°ã«ã¿ãã³é
ž
ïŒãããªãŠã å¡©ïŒã®ãŠãããæ°ã¯ãïŒãŠãããã®
質éæ°ã151ã§ããããšã«ããã118ãšèšç®ãã
ãã
åå¿åŸãã»ãã¢ããã¯ã¹ïŒ§â25ïŒ1.0Ã40cmã
0.01Mãªã³é
žç·©è¡¡æ¶²â1m MEDTAïŒPH6.0ïŒïŒã«é
ããŠäœååç©è³ªãé€å»ãããšãâæ«ç«¯ã«ããªãŒ
ã«åºãæããããªââã°ã«ã¿ãã³é
žã®æº¶æ¶²ãåŸ
ãããã
å®æœäŸ ïŒ
ïŒâïŒ ïŒ®âæ«ç«¯ã«ä¿è·ãããããªãŒã«åºãå«ã
ã¢ã·ã«åºãå°å
¥ãããã°ã«ã¿ãã³é
žãšã¢ã©ãã³
å
±éåäœã®è£œé ã
âã°ã«ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®å
±éåäœã®
ãããªãŠã ïŒå¹³åååé17200ãã°ã«ã¿ãã³é
žâ
ã¢ã©ãã³æ§æåœéæ¯30.3ïŒïŒïŒã172mgã®ããªã¹â
å¡©é
žç·©è¡¡æ¶²ïŒPH8.2ïŒïŒ10mlïŒäžæº¶æ¶²ã«ãâã¢ã»
ãã«ãã¢ã·ã¹ãã€ã³ããªã©ã¯ãã³48mgã®ãšã¿ããŒ
ã«ïŒïŒmlïŒæº¶æ¶²ãïŒåºŠã«ãããŠå ãã枩床äžã§10
æéæ¹æãããåå¿æ¶²ãã»ããã¢ã³éæããŠãŒã
ã«å
¥ãã1m MEDTAâ0.01Mãªã³é
žç·©è¡¡æ¶²ïŒPH
6.0ïŒã«å¯ŸããŠïŒâã§ïŒæ¥ééæããäœååç©è³ª
ãé€ããšãâã°ã«ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®å
±
éåäœã®ã¢ããæ«ç«¯ã«ãâã¢ã»ãã«ãã¢ã·ã¹ã
ã€ã³ãã¢ããçµåã«ããå°å
¥ãããŠçæãããã
ãªãŒã«åºãæããéåäœãå«æãã溶液16mlãåŸ
ãããã
å®æœäŸïŒâïŒïŒã§ç€ºãããšåãæ¹æ³ãå³ã¡ãã
ãªãããã«ã»ãã¢ããŒã¹6Bã²ã«ã«ããªãŒã«åºã
å°å
¥ãããéåäœããã€ããçµåããããªãŒã«åº
ãå°å
¥ãããªãã€ããæªåå¿éåäœãé€ãã次ã
ã§ããªãŒã«åºãå°å
¥ãããéåäœãã²ã«ãã溶åº
ããæ¹æ³ã«ãã€ãŠããªãŒã«åºãæããéåäœã®ç²Ÿ
補åãåŸãïŒæ²æŸ±ç©ïŒã
ïŒâïŒ ïŒ®âæ«ç«¯ã«æŽ»æ§ãžã¹ã«ãã€ãåºãæãã
âã°ã«ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®å
±éåäœã®
補é ã
ïŒâïŒïŒã§åŸããããæ«ç«¯ã«ããªãŒã«åºãæã
ãâã°ã«ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®å
±éåäœã®
æ²æŸ±ã«ãåã³0.4Mãªã³é
žç·©è¡¡æ¶²â1m MEDTA
ïŒPH7.5ïŒïŒmlãå ããŠæº¶è§£ããåŸããã溶液ã«ã
å®æœäŸïŒâïŒïŒãšåæ§ã«ïŒâPDSãå ããŠåå¿
ããããããã«éæãåçµä¹Ÿç¥ã®åŠçå·¥çšãæœã
ãŠãç®çç©ã§ãããæ«ç«¯ã«ïŒâããªãžã«ãžããªåº
ãå°å
¥ãããâã°ã«ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®
å
±éåäœïŒãããªãŠã å¡©ïŒã®ç¶¿ç¶åºäœã22.4mgã
åŸãïŒééåç13ïŒ
ïŒãå®æœäŸïŒâïŒïŒã®çµæã
ããåŸãããéåäœã¯æ«ç«¯ã«ïŒâããªãžã«ãžããª
åºãå«æããŠãããååéã¯13900ã§ããã
ïŒâïŒ ïŒ®âæ«ç«¯ã«ããªãŒã«åºãæããâã°ã«
ã¿ãã³é
žãšïŒ¬âã¢ã©ãã³ã®å
±éåäœã®è£œé ã
2.2ïŒã§åŸãããæ«ç«¯ã«ïŒâããªãžã«ãžããªåº
ãå«æããéåäœ1.154mgã粟秀ããå®æœäŸïŒâ
ïŒïŒãšåæ§ã«ããžããªã¹ã¬ã€ããŒã«ãšåå¿ããã
ããéé¢ããïŒâã¡ã«ã«ããããªãžã³ã«ç±æ¥ãã
åžåã枬å®ããŠãåãµã³ãã«äžã®æ«ç«¯æŽ»æ§åºéã
éåäœã®ååéãç®åºãããæ«ç«¯æŽ»æ§åºé
0.083ÎŒmoleãååé13900ã
åå¿æ¶²ã0.01Mãªã³é
žç·©è¡¡æ¶²â1m MEDTA
ïŒPH6.0ïŒã«éæããŠãäœååç©è³ªãé€ããšãâ
æ«ç«¯ã«ããªãŒã«åºãæããâã°ã«ã¿ãã³é
žãšïŒ¬
âã¢ã©ãã³ã®å
±éåäœã®æº¶æ¶²ãåŸãããã
å®æœäŸ ïŒ
ïŒâïŒ ïŒ®âæ«ç«¯ã«ããªãŒã«åºãå«ãããªââ
ã°ã«ã¿ãã³é
žã®è£œé ã
ããªââã°ã«ã¿ãã³é
žã®ãããªãŠã å¡©ïŒå¹³å
ååé17000ïŒ170mgã0.1Mãªã³é
žãããªãŠã ç·©
衡液ïŒPH7.3ïŒïŒmlã«æº¶è§£ããâã¢ã»ãã«ã¡ã«
ã«ããç¡æ°Žã³ãã¯é
ž346mgããžã¡ãã«ãã«ã ã¢ã
ã2.0mlã«æº¶è§£ãããã®ãïŒåã«ãããŠå ããPH
ã7.0ã7.5ã®éã«ä¿ã¡ã€ã€ã宀枩äžã«ïŒæéæ¹æ
ããã次ãã§åå¿æ¶²ãã»ããã¢ã³éæããŠãŒãã«
å
¥ãã0.01Mãªã³é
žç·©è¡¡æ¶²ïŒPH7.5ïŒã«å¯ŸããŠïŒ
âã§å
åéæãããåå液8.5mlã0.5Mãããã
ã·ã«ã¢ãã³æº¶æ¶²2.5mlãå ãã30âã«ãŠ30åéå
å¿ããããããªãŒã«åºãä¿è·ããŠããã¢ã»ãã«åº
ãè±é¢ãããããïŒâã«ãŠåå¿æ¶²ã«1NHClãå
ããŠPHã2.0ãšããïŒæéæŸçœ®ããã®ã¡ãçãã
æ²æŸ±ãé å¿åé¢ãããšãâæ«ç«¯ã«ããªãŒã«åºã
å°å
¥ãããããªââã°ã«ã¿ãã³é
žã®æ²æŸ±ãåŸã
ããã
ããã«ïŒâïŒïŒã§ç€ºãããšåãæ¹æ³ãå³ã¡ããª
ãããã«ã»ãã¢ããŒã¹6Bã²ã«ã«ããªãŒã«åºãå°
å
¥ãããéåäœããã€ããçµåããããªãŒã«åºã
å°å
¥ãããªãã€ãæªåå¿ã®éåäœãé€ãã次ãã§
ããªãŒã«åºãå°å
¥ãããéåäœãã²ã«ãã溶åºã
ãããæ¹æ³ã«ãããããªãŒã«åºãæããéåäœã®
粟補åãåŸãå¡©é
žé
žæ§ã«ããæ²æŸ±ç©ãšããŠåŸãã
ïŒâïŒ ïŒ®âæ«ç«¯ã«æŽ»æ§ãžã¹ã«ãã€ãåºãæãã
ããªââã°ã«ã¿ãã³é
žã®è£œé ã
ïŒâïŒïŒã§åŸããããæ«ç«¯ã«ããªãŒã«åºãæã
ãããªââã°ã«ã¿ãã³é
žã®æ²æŸ±ããåã³0.4M
ãªã³é
žãããªãŠã â1m MEDTA緩衡液ïŒPH7.6ïŒ
ïŒmlã«ãšãããããã«ïŒïŒ5â²âãžããªãã¹ïŒïŒâ
ãããå®æ¯éŠé
žïŒ39.6mgãå ããŠæº¶è§£ãã30åé
åå¿ãããããåå¿æ¶²ã«ã»ããã¢ã³ããŠãŒãã«å
¥
ããïŒâã«ãŠæ°Žã«å¯ŸããŠå
åéæãããåå液ã
åçµä¹Ÿç¥ãããšãç®çç©ã§ãããïŒâãããâïŒ
âã«ã«ããã·ããšãã«ãžããªåºãäž»éã«ïŒ®âæ«ç«¯
ã«å«æããããªââã°ã«ã¿ãã³é
žïŒãããªãŠã
å¡©ïŒã®ç¶¿ç¶åºäœ29.6mgãåŸãããïŒééåç17.4
ïŒ
ïŒãå®æœäŸ3.3ïŒã®çµæãããåŸãããéåäœ
ã¯ãæ«ç«¯ã«ïŒâãããâïŒâã«ã«ããã·ããšãã«
ãžããªåºãå«æããŠãããååéã¯14900ã§ããã
ïŒâïŒ ïŒ®âæ«ç«¯ã«ããªãŒã«åºãæããããªâ
âã°ã«ã¿ãã³é
žã®è£œé ã
ïŒâïŒïŒã§åŸããããæ«ç«¯ã«ïŒâãããâïŒâ
ã«ã«ããã·ããšãã«ãžããªåºãå«æããŠããéå
äœ2.208mgã粟秀ãã0.1Mãªã³é
žç·©è¡¡æ¶²3.00mlã«
溶解ããã10mM2âã¡ã«ã«ãããšã¿ããŒã«0.10
mlãå ãã30åéæŸçœ®ããåŸãéé¢ããïŒâã¡ã«
ã«ããâïŒâãããå®æ¯éŠé
žã«ç±æ¥ãã412nmã«
ãããåžåïŒÎµïŒ12000ïŒã枬å®ããæ«ç«¯æŽ»æ§åº
éãå®éããéåäœã®ååéãç®åºãããæ«ç«¯æŽ»
æ§åºé0.148ÎŒmoleãååé14900ã
åå¿æ¶²ã0.01Mãªã³é
žç·©è¡¡æ¶²â1m MEDTA
ïŒPH5.8ïŒã«éæããŠãäœååç©è³ªãé€ããšãâ
æ«ç«¯ã«ããªãŒã«åºãæããããªââã°ã«ã¿ãã³
é
žã®æº¶æ¶²ãåŸãããã[Formula] N-phenylamino-N'-phenyliminomethyl disulfide can be mentioned. Both reactions are usually carried out in a homogeneous reaction system using water or an organic solvent such as dimethylformamide or dimethyl sulfoxide as a reaction solvent. Alternatively, the reaction can be carried out using a reaction system in which an active disulfide compound or its acetone solution, dioxane solution, etc. are added to and mixed with an aqueous solution of the polymer. The reaction temperature is -5°C to 70°C, and the reaction time is suitably 1 minute to 24 hours. For purification after the reaction, add a buffer to the reaction solution,
A method for precipitating and removing a polymer with acidity,
This can be easily carried out by dialysis of the reaction solution and then freeze-drying. Next, the reactive polymer having the active group represented by the formula [-b] at the amino end of the main chain is added to the amino end of the main chain, and the reactive polymer having the active group represented by the formula [-a] is added to the amino end of the main chain. A method for converting the compound into a reactive polymer having a group will be described. Preferably, the method is one in which the disulfide group is reductively cleaved. Examples of the reducing agent used include thiols such as 2-mercaptoethanol and dithiothreitol, and borohydride compounds such as sodium borohydride and calcium borohydride. The reaction solvent is preferably water or dimethylformamide.
The amount of reducing agent used is preferably 1 to 100 equivalents. The reaction temperature is preferably 0 to 50°C and the reaction time is preferably 1 minute to 3 hours. Purification is carried out by conventional acid precipitation, gel filtration, dialysis, etc. The reactive polymer of the present invention has a large number of highly reactive carboxyl groups (or salts thereof) in the side chain,
Since it has a highly reactive thiol group or active disulfide bond at the end of the molecule, the reactivity of these groups can be used to effectively and efficiently bind immunoglobulins and cytotoxins, for example, by the method described below. The resulting conjugate can be used as a targeted drug. As the cytotoxic substance introduced into the side chain, for example, an anticancer agent containing an amino group or an imino group in the molecule is used. The reaction between the reactive polymer of the present invention and the cytotoxic substance is usually carried out in a homogeneous reaction system using water or an organic solvent such as dimethylformamide or dimethyl sulfoxide as a reaction solvent. In the reaction, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride may be used to activate the carboxyl groups in the polymer with dicyclohexylcarbodiimide, or the carboxyl groups may be activated in the form of a mixed acid anhydride. You may also leave it as Appropriate reaction temperature is -40°C to 100°C and reaction time is 10 minutes to 10 days. e Effects of the invention The reactive polymer thus obtained with a cytotoxic substance bound to its side chain still has a highly reactive thiol group or active disulfide bond at the molecular end, so the reaction of such a group or bond is difficult. The reactive polymer of the present invention to which a cytotoxic agent is bound can be obtained by bonding the anti-tumor immunoglobulin or its fragment by utilizing the reactivity of the thiol group, active disulfide group, maleimide group, etc. generated or introduced into the anti-tumor immunoglobulin or its fragment. It is possible to produce a complex having antitumor properties in which the toxic portion is used. Specific manufacturing methods include, for example, the following methods. Antitumor immunoglobulin was treated with pepsin,
A dimer of Fab' is obtained, and the disulfide bond at the hinge portion is reductively cleaved using, for example, a thiol reagent to have a thiol group in the molecule.
Obtain Fabâ². and has a thiol group
Fab' is reacted with the reactive polymer of the present invention having an active disulfide bond and a polymer further bound to a cytotoxic substance to obtain the desired antitumor complex. An antitumor immunoglobulin into which a maleimide group has been introduced by, for example, acting with succinimidyl m-maleimidobenzoate is reacted with a polymer in which a cytotoxic substance is further bonded to the reactive polymer of the present invention having a thiol group. to obtain the desired antitumor conjugate. The antitumor agent thus obtained is expected to exert toxicity on tumor cells to which it selectively binds. Hereinafter, the present invention will be explained in detail with reference to Examples. Example 1 1-1 Production of poly-L-glutamic acid into which an acyl group containing a protected thiol group is introduced at the amino terminal (hereinafter abbreviated as N-terminus). To a solution of 226.5 mg of sodium salt of poly-L-glutamic acid (average molecular weight 21000) in 0.1 M sodium phosphate buffer (PH 7.5) (15 ml) was added N-succiimidyl 3-(2-pyridyldithio) propionate (hereinafter referred to as A solution of 68.8 mg (abbreviated as SPDP) in ethanol (6 ml) was added in two portions under stirring, and the mixture was allowed to react at room temperature for 1.5 hours. Place the reaction solution in a cellophane dialysis tube and add 0.01M phosphate buffer (PH7.5).
When low-molecular substances are removed by dialysis at 4°C for 2 days against poly-L-glutamic acid, a 3-(2-pyridyldithio)propionyl group is introduced into the amino terminal of the poly-L-glutamic acid molecule through an amide bond, resulting in a disulfide bond. 50 ml of a solution containing poly-L-glutamic acid were obtained. 1-2 Poly-L having a thiol group at the N-terminus
- Production of glutamic acid. 1-1), 3-
Add 17 mg of dithiothreitol to 50 ml of a solution containing poly-L-glutamic acid with a disulfide bond into which a (2-pyridyldithio)propionyl group has been introduced and a 0.1 M sodium phosphate (PH6.0) buffer solution.
A 2.0 ml solution was added, and the mixture was allowed to react at room temperature for 80 minutes.
The mixture was then acidified with hydrochloric acid, and the resulting precipitate was centrifuged. Precipitate of the obtained poly-L-glutamic acid (contains poly-L-glutamic acid with and without a thiol group at the end)
was washed with 0.01NHCl. Meanwhile, 15 ml of Thiopropyl Sepharose 6B gel (manufactured by Pharmacia) was mixed with 0.1 M sodium phosphate (PH6.0).
1mM ethylenediaminetetraacetic acid (hereinafter EDTA)
(abbreviated as ) (PH6.0) buffer solution, and to the obtained dispersion solution, a solution obtained by dissolving the poly-L-glutamic acid obtained above in 10 ml of the same buffer solution was added, and the solution was heated to room temperature. 1 in a nitrogen atmosphere.
Stirred overnight. This binds poly-L-glutamic acid having a thiol group at the end to the resin. The resin was then filtered and thoroughly washed with 0.01M phosphoric acid buffer pH 7.5. The thus obtained resin was diluted with 0.1M Tris-hydrochloric acid.
The mixture was dispersed in 50 ml of 1m MEDEA (PH8.5) buffer solution, 1.17 g of 2-mercaptoethanol was added, and the mixture was gently stirred at room temperature in a nitrogen atmosphere for 10 hours. As a result, poly-L-glutamic acid having a thiol group at the end is released from the resin. Filter the resin and add 0.01M Tris-HCl-0.1m
Wash thoroughly with MEDTA (PH8.5) buffer, then
The filtrate and washing solution were adjusted to pH 1.8 with hydrochloric acid under ice-cooling, and the resulting precipitate of poly-L-glutamic acid having a thiol group at its terminal was centrifuged. 1-3 Production of poly-L-glutamic acid having an active disulfide group at the N-terminus. The precipitate of poly-L-glutamic acid having a thiol group at the end obtained in step 1-2) was added to the 0.4M sodium phosphate-1mMEDTA (PH7.5) buffer solution 1 again.
A solution of 23 mg of 2-pyridyl disulfide (hereinafter abbreviated as 2-PDS) in ethanol (4 ml) was dissolved in 0.1 M sodium phosphate.
Add to the resulting solution by adding 10 ml of 1m MEDTA (PH6.0) and react for 30 minutes at room temperature.
Put the reaction solution (the terminal of L-glutamic acid becomes an active disulfide group) into a cellophane tube,
Dialysis was performed against 0.01M sodium phosphate (PH7.5) buffer for 6 hours and against pure for 1 day. The recovered liquid was reduced to 30 ml under reduced pressure and freeze-dried to obtain 35.4 mg of a flocculent solid of poly-L-glutamic acid (sodium salt) with a 2-pyridyldithio group introduced at its terminal (weight yield 15.6%). ). From the results of Example 1-4), the obtained polymer contains a 2-pyridyldithio group at the end and has a molecular weight of 17,800. 1-4 Poly-L having a thiol group at the N-terminus
-Process for producing glutamic acid. Accurately weigh a certain amount of sample (1.895mg) and 3.00ml
A small piece of dithiothreitol was added to the solution in 0.1M sodium phosphate buffer (PH7.2), and the absorption (343 nm, molecular extinction coefficient ε = 8080) derived from liberated 2-mercaptopyridine was measured ( A=0.286). The amount of terminal groups in the accurately weighed sample is 0.1062 Όmole. Therefore, the molecular weight of the terminal active disulfide-containing poly-L-glutamic acid molecule in the same sample is 17800, and the number of units of glutamic acid (sodium salt) in the same molecule is was calculated to be 118 since the mass number of one unit is 151. After the reaction, transfer to Cephadex G-25 (1.0 x 40 cm,
When low-molecular substances were removed by passing through 0.01M phosphoric acid buffer - 1m MEDTA (PH6.0)), a solution of poly-L-glutamic acid having a thiol group at the N-terminus was obtained. Example 2 2-1 Production of a glutamic acid and alanine copolymer into which an acyl group containing a protected thiol group is introduced at the N-terminus. Sodium copolymer of L-glutamic acid and L-alanine (average molecular weight 17200, glutamic acid-
Alanine constituent equivalent ratio 30.3:1), 172 mg Tris-
A solution of 48 mg of N-acetyl homocysteine thiolactone in ethanol (4 ml) was added in two portions to a solution in hydrochloric acid buffer (PH8.2) (10 ml), and the mixture was heated for 10 min at room temperature.
Stir for hours. Pour the reaction solution into a cellophane dialysis tube and dilute with 1m MEDTA-0.01M phosphate buffer (PH
6.0) at 4°C for 2 days to remove low-molecular substances, N-acetylhomocysteine was introduced into the amino terminal of the copolymer of L-glutamic acid and L-alanine through an amide bond. , 16 ml of a solution containing a polymer having thiol groups was obtained. The same method as shown in Example 1-2) was used, that is, the polymer into which a thiol group had been introduced was once bonded to the thiopropyl Sepharose 6B gel, and the unreacted polymer into which no thiol group had been introduced was removed. Next, a purified product of a polymer having a thiol group was obtained by eluting the polymer having a thiol group from the gel (precipitate). 2-2 Production of a copolymer of L-glutamic acid and L-alanine having an active disulfide group at the N-terminus. To the precipitate of the copolymer of L-glutamic acid and L-alanine having a thiol group at the end obtained in 2-1), add 0.4M phosphoric acid buffer and 1m MEDTA again.
(PH7.5) Add and dissolve 2 ml, and to the resulting solution,
2-PDS was added and reacted in the same manner as in Example 1-2), and further treatment steps of dialysis and freeze-drying were performed to obtain the target product, L-glutamic acid with a 2-pyridyldithio group introduced at the end. 22.4 mg of a flocculent solid of L-alanine copolymer (sodium salt) was obtained (weight yield: 13%). From the results of Example 2-3), the obtained polymer contains a 2-pyridyldithio group at the end and has a molecular weight of 13,900. 2-3 Production of a copolymer of L-glutamic acid and L-alanine having a thiol group at the N-terminus. 1.154 mg of the polymer containing a 2-pyridyldithio group at the end obtained in 2.2) was accurately weighed, and Example 1-
It was reacted with dithiothreitol in the same manner as in 4). By measuring the absorption derived from liberated 2-mercaptopyridine, the amount of terminal active groups in the same sample,
The molecular weight of the polymer was calculated. Terminal active group amount
0.083ÎŒmole, molecular weight 13900. The reaction solution was mixed with 0.01M phosphate buffer - 1m MEDTA.
(PH6.0) to remove low molecular weight substances, N-
L-glutamic acid with a thiol group at the end and L
- A solution of a copolymer of alanine was obtained. Example 3 3-1 Poly-L- containing a thiol group at the N-terminus
Production of glutamic acid. 170 mg of sodium salt of poly-L-glutamic acid (average molecular weight 17000) was dissolved in 5 ml of 0.1 M sodium phosphate buffer (PH7.3), and 346 mg of S-acetylmercaptosuccinic anhydride was dissolved in 2.0 ml of dimethylformamide. Add in two times and adjust the pH
While maintaining the temperature between 7.0 and 7.5, the mixture was stirred at room temperature for 2 hours. Next, the reaction solution was placed in a cellophane dialysis tube and diluted with 0.01M phosphate buffer (PH7.5).
It was thoroughly dialyzed at â. 8.5ml of recovery liquid. 2.5 ml of 0.5M hydroxylamine solution was added and reacted at 30°C for 30 minutes to remove the acetyl group protecting the thiol group. 1NHCl was added to the reaction solution at 0°C to adjust the pH to 2.0, and after standing for 2 hours, the resulting precipitate was centrifuged to obtain a precipitate of poly-L-glutamic acid with a thiol group introduced at the N-terminus. Ta. Furthermore, using the same method as shown in 1-2), that is, the polymer into which thiol groups have been introduced is bonded to the thiopropyl Sepharose 6B gel, the unreacted polymer into which thiol groups have not been introduced is removed, and then the thiol A purified product of a polymer having a thiol group was obtained by eluting the polymer into which the group had been introduced from the gel, and a precipitate was obtained by acidifying with hydrochloric acid. 3-2 Production of poly-L-glutamic acid having an active disulfide group at the N-terminus. The precipitate of poly-L-glutamic acid having a thiol group at the end obtained in 3-1) was added to 0.4M again.
Sodium phosphate - 1m MEDTA buffer (PH7.6)
Dissolve to 2 ml and add 5,5'-dithiobis(2-
39.6 mg of nitrobenzoic acid) was added and dissolved, and the mixture was allowed to react for 30 minutes. The reaction solution was poured into a cellophane tube and thoroughly dialyzed against water at 4°C. When the recovered liquid is freeze-dried, the target product, 4-nitro-3
-29.6 mg of a flocculent solid of poly-L-glutamic acid (sodium salt) containing a carboxyphenyl dithio group at the N-terminus in the main chain was obtained (weight yield 17.4
%). From the results of Example 3.3), the obtained polymer contains a 4-nitro-3-carboxyphenyldithio group at the end and has a molecular weight of 14,900. 3-3 Poly-L having a thiol group at the N-terminus
- Production of glutamic acid. 3-2), with 4-nitro-3- at the end
2.208 mg of a polymer containing carboxyphenyl dithio groups was accurately weighed and dissolved in 3.00 ml of 0.1M phosphoric acid buffer. 10mM2-Mercaptoethanol 0.10
ml and left for 30 minutes, the absorption at 412 nm (ε = 12000) derived from liberated 5-mercapto-2-nitrobenzoic acid was measured, the amount of terminal active groups was quantified, and the molecular weight of the polymer was calculated. did. Terminal active group amount 0.148Όmole, molecular weight 14900. The reaction solution was mixed with 0.01M phosphate buffer - 1m MEDTA.
(PH5.8) to remove low molecular weight substances, N-
A solution of poly-L-glutamic acid having a thiol group at the end was obtained.
Claims (1)
ããæ§æåäœãããªãã ãåŒïŒ»ïŒœã«ãããŠãã¯æ°ŽçŽ åååã¯ïŒäŸ¡ã®
éœã€ãªã³ãè¡šãããïœã¯ïŒãïŒã®æŽæ°ãè¡šãããã åŒïŒ»ïŒœã®æ§æåäœã100ã¢ã«ïŒ ã§ãªããšãã
æ®ãã®æ§æåäœã¯ãåŒïŒ»â²ïŒœ ãåŒïŒ»â²ïŒœã«ãããŠãã¯âïŒâCH3ïŒ
ãåŒããŸãã¯âCH2OHã§è¡šããã ãåºã§ãããã ã§è¡šããããæ§æåäœãããªããéå床ãïŒã
3000ã®èŠªæ°Žæ§éåäœã«ãåŒïŒ»ïŒœ R1SââCOâR2 âŠãã ãåŒäžãã¯ççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åºãè¡š
ãããR1ã¯ããªãŒã«åºã®ä¿è·åºãè¡šãããR2ã¯
é£æ¥ããã«ã«ããã«åºã掻æ§åãåŸãåºãè¡šã
ããã ã§è¡šãããããä¿è·ãããããªãŒã«åºãå«æãã
ã¢ã·ã«åå€ãåå¿ãããã次ãã§ããªãŒã«åºã®ä¿
è·åºãé€å»ããããšãç¹åŸŽãšãããæ§æåäœã®60
ã¢ã«ïŒ 以äžãåŒïŒ»ïŒœã§è¡šããããæ§æåäœãã
ãªãã ãåŒïŒ»ïŒœã«ãããŠãã¯æ°ŽçŽ åååã¯ïŒäŸ¡ã®
éœã€ãªã³ãè¡šãããïœã¯ïŒãïŒã®æŽæ°ãè¡šãããã åŒïŒ»ïŒœã®æ§æåäœã100ã¢ã«ïŒ ã§ãªããšãã
æ®ãã®æ§æåäœã¯ãåŒïŒ»â²ïŒœ ãåŒïŒ»â²ïŒœã«ãããŠãã¯âïŒâCH3ïŒ
ãåŒããŸãã¯âCH2OHã§è¡šããã ãåºã§ãããã ã§è¡šããããæ§æåäœãããªãããããŠäž»éã®ã¢
ããæ«ç«¯ã«åŒãâïœãã§è¡šãããã掻æ§åºãæ
ããŠããã ãåŒïŒ»âïœïŒœã«ãããŠãã®å®çŸ©ã¯åèšåŒ
ã®å Žåãšåããã éå床ãïŒã3000ã®åå¿æ§éåäœã®è£œé æ³ã ïŒ æ§æåäœã®60ã¢ã«ïŒ 以äžãåŒïŒ»ïŒœã§è¡šãã
ããæ§æåäœãããªãã ãåŒïŒ»ïŒœã«ãããŠãã¯æ°ŽçŽ åååã¯ïŒäŸ¡ã®
éœã€ãªã³ãè¡šãããïœã¯ïŒâïŒã®æŽæ°ãè¡šãããã åŒïŒ»ïŒœã®æ§æåäœã100ã¢ã«ïŒ ã§ãªããšãã
æ®ãã®æ§æåäœã¯ãåŒïŒ»â²ïŒœ ãåŒïŒ»â²ïŒœã«ãããŠãã¯âïŒâCH3ïŒ
ãåŒããŸãã¯âCH2OHã§è¡šããã ãåºã§ãããã ã§è¡šããããæ§æåäœãããªãããããŠäž»éã®ã«
ã«ããã·ã«æ«ç«¯ã«åŒïŒ»âïœïŒœã§è¡šãããã掻æ§
åºãæããŠããã ãåŒïŒ»âïœïŒœã«ãããŠãã¯ççŽ æ°ïŒãïŒã®
ã¢ã«ãã¬ã³åºãè¡šãããX1ã¯é£ãã®ç¡«é»ååãš
å ±ã«æŽ»æ§ãžã¹ã«ãã€ãçµåã圢æãããåºãè¡šã
ããã ã§è¡šãããã掻æ§åºãæããŠãããéå床ãïŒã
3000ã®åå¿æ§éåäœã®ãžã¹ã«ãã€ãçµåãéå ç
ã«åæããããšãç¹åŸŽãšãããæ§æåäœã®60ã¢ã«
ïŒ ä»¥äžãåŒïŒ»ïŒœã§è¡šããããæ§æåäœãããª
ããäž»éã®ã¢ããæ«ç«¯ã«åŒãâïœãã§è¡šããã
ã掻æ§åºãæããŠãããéå床ãïŒã3000ã®åå¿
æ§éåäœã®è£œé æ³ã ãåŒïŒ»âïœïŒœã«ãããŠãã®å®çŸ©ã¯åèšåŒ
âïœïŒœã®å Žåãšåããã[Scope of Claims] 1 60 mol% or more of the structural units consist of structural units represented by the formula [], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer from 1 to 4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [â²] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of the structural unit represented by
3000 hydrophilic polymer, the formula [] R 1 S-W-CO-R 2 ... [] [In the formula, W represents an alkylene group having 1 to 4 carbon atoms. R 1 represents a protecting group for a thiol group. R 2 represents a group capable of activating an adjacent carbonyl group. ] 60 of the structural unit characterized by reacting with an acylating agent containing a protected thiol group, and then removing the protecting group of the thiol group.
At least mol% consists of the structural unit represented by the formula [ ], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer from 1 to 4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [â²] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-a] at the amino terminal of the main chain, [In formula [-a], the definition of W is the same as in the above formula []. ] A method for producing a reactive polymer having a degree of polymerization of 5 to 3000. 2 60 mol% or more of the structural units consist of structural units represented by the formula [], [In formula [], Z represents a hydrogen atom or a monovalent cation. m represents an integer of 1-4. ] When the constituent units of formula [] are not 100 mol%,
The remaining structural units are expressed by the formula [â²] [In formula ['], R is -H, -CH 3 ,
It is a group represented by [Formula] or -CH 2 OH. ] Consisting of a structural unit represented by the following, and having an active group represented by the formula [-b] at the carboxyl terminal of the main chain, [In formula [-b], W represents an alkylene group having 1 to 4 carbon atoms. X 1 represents a group capable of forming an active disulfide bond with the adjacent sulfur atom. ] Having an active group represented by
3000 is characterized by reductively cleaving the disulfide bonds of the reactive polymer, in which 60 mol% or more of the structural units are structural units represented by the formula [], and the amino terminal of the main chain has the formula [-a ] A method for producing a reactive polymer having an active group represented by the following and having a degree of polymerization of 5 to 3,000. [In formula [-a], the definition of W is the same as in the above formula [-b]. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3295683A JPS59159828A (en) | 1983-03-02 | 1983-03-02 | Reactive polymer and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3295683A JPS59159828A (en) | 1983-03-02 | 1983-03-02 | Reactive polymer and its production |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59159828A JPS59159828A (en) | 1984-09-10 |
JPH0149299B2 true JPH0149299B2 (en) | 1989-10-24 |
Family
ID=12373375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3295683A Granted JPS59159828A (en) | 1983-03-02 | 1983-03-02 | Reactive polymer and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59159828A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9007384D0 (en) * | 1990-04-02 | 1990-05-30 | Duncan Ruth | Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups |
CA2656077C (en) * | 2006-06-15 | 2014-12-09 | Marc Mckennon | A process for the preparation of poly-alpha-glutamic acid and derivatives thereof |
GB2509972A (en) * | 2013-01-21 | 2014-07-23 | Gm Global Tech Operations Inc | Shift mechanism with shift finger having a damping member |
US10077323B2 (en) * | 2015-07-24 | 2018-09-18 | Bridgestone Corporation | Polymers functionalized with imine compounds containing a protected thiol group |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5718727A (en) * | 1980-07-07 | 1982-01-30 | Teijin Ltd | Reactive polymer and its preparation |
JPS5730724A (en) * | 1980-07-31 | 1982-02-19 | Teijin Ltd | Polymer having disulfide bond in molecule and its preparation |
-
1983
- 1983-03-02 JP JP3295683A patent/JPS59159828A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5718727A (en) * | 1980-07-07 | 1982-01-30 | Teijin Ltd | Reactive polymer and its preparation |
JPS5730724A (en) * | 1980-07-31 | 1982-02-19 | Teijin Ltd | Polymer having disulfide bond in molecule and its preparation |
Also Published As
Publication number | Publication date |
---|---|
JPS59159828A (en) | 1984-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU723442B2 (en) | Method for preparing drug complex | |
US4385169A (en) | Reactive alpha amino acid polymer | |
AU723392B2 (en) | Drug complex | |
US5548064A (en) | Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions | |
JPH064678B2 (en) | Method for producing antibody complex | |
JPH048411B2 (en) | ||
US5738864A (en) | Drug delivery agents incorporating mitomycin | |
JPH0149299B2 (en) | ||
EP3166644B1 (en) | Method of synthesising adcs using photocleavable linkers on solid support | |
WO1991015242A1 (en) | Conjugate compounds of polymers with other organic molecular entities | |
JPS6238368B2 (en) | ||
JPH0149298B2 (en) | ||
JPS6219770B2 (en) | ||
Veronese et al. | Preparation and properties of monomethoxypoly (ethylene glycol)-modified enzymes for therapeutic applications | |
Palacios et al. | Novel solid-phase synthesis of thiol-terminated-poly (α-amino acid)-drug conjugate | |
JPH0338294B2 (en) | ||
WO1987004171A1 (en) | Process for preparing antibody complex | |
AU2002255172B2 (en) | Soluble protein-polymer systems for drug delivery | |
JPS60168726A (en) | Cytotoxic substance-bound reactive polymer and its production | |
JPH10509208A (en) | Functionalized polymers for site-specific binding | |
JPS6238369B2 (en) | ||
JPS6119635A (en) | Cytotoxic substance and protein complex | |
VERONESE et al. | and L. SARTORE | |
JPH0428000B2 (en) | ||
JPH029564B2 (en) |